Home » Topics » BioWorld Science

BioWorld Science
RSS

Another NeuroSearch compound for nerve degeneration

Sep. 6, 1996

NeuroSearch compound for the treatment of brain damage

Sep. 6, 1996

New adenosine A3 receptor antagonist reported at ACS

Sep. 6, 1996

Potential new treatment for Alzheimer's disease disclosed by SIBIA Neurosciences

Sep. 6, 1996

INSERM and Bioprojet describe a new histamine H3 receptor antagonist

Sep. 6, 1996

Tiagabine clinical data reported at congress this week

Sep. 6, 1996

Fosphenytoin launch imminent

Sep. 6, 1996

Mechanism-based enzyme inhibitor may serve as a lead for new anticonvulsants

Sep. 6, 1996

Xenova forms new U.S. subsidiary

Sep. 6, 1996

ICN to acquire Hungarian pharmaceutical company

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...